Skip to main content
MedicHelpLine
Join Free
Verified Professional Network190+ CountriesHIPAA-Aware Platform
Back to Drug Index
General MedicationsINJECTIONGeneric

BORTEZOMIB

BORTEZOMIB

Standard Dose
3.5MG/1.4ML
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: None (Tentative Approval)
Summary

Approval overview BORTEZOMIB is listed in Drugs@FDA under application 208645 (NDA).

Review priority: STANDARD Marketing status: None (Tentative Approval) Active ingredient BORTEZOMIB Form and strength INJECTABLE; INJECTION - 3.5MG/1.4ML Sponsor ACTAVIS LLC Submission history Latest submission status date: 2016-10-20 00:00:00.

Structured Monograph

Clinical summary

Approval overview BORTEZOMIB is listed in Drugs@FDA under application 208645 (NDA). Review priority: STANDARD Marketing status: None (Tentative Approval) Active ingredient BORTEZOMIB Form and strength INJECTABLE; INJECTION - 3.5MG/1.4ML Sponsor ACTAVIS LLC Submission history Latest submission status date: 2016-10-20 00:00:00. Submission type: ORIG.

Monitoring

  • • Marketing status: None (Tentative Approval)
  • • Review priority: STANDARD

Interaction Notes

  • No interaction notes stored yet.